ArticleTherapeutic advances in endocrinology and metabolism2021

Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease.

Miguel Ángel Gómez-Sámano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.